SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt’s Q3 consolidated net surges over 50%

14 Feb 2012 Evaluate

Drug firm, Wockhardt’s consolidated net profit rose by 50.21% to Rs 212.81 crore in the third quarter ended December 31, 2011, on the back of strong sales in the US market. The company had posted a net profit of Rs 141.67 crore for the corresponding period last fiscal.

Net sales of the company rose by 27.12% to Rs 1,208.67 crore in the quarter ended December 31, 2011, from Rs 950.80 crore in the same period last fiscal.

On a standalone basis, the company posted a net profit of Rs 116.16 crore for the third quarter, as against Rs 66.66 crore for the same period last financial year.

Wockhardt Share Price

1606.90 -29.85 (-1.82%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×